Canopy Growth management commentary attributes wider Q2 FY2027 net loss to swing in other income and expenses
- Canopy Growth management commentary attributed its fiscal second-quarter 2027 net loss of CAD 40.7 million primarily to unfavorable fair-value movements and higher operating expenses.
- Revenue rose 22% to CAD 81.37 million, driven by the MTL acquisition, insured medical customer growth and stronger European cannabis sales.
- Gross margin fell to 29% from 33%, primarily reflecting reduced medical cannabis reimbursement rates; acquired inventory step-up costs also weighed.
- Adjusted EBITDA loss narrowed to CAD 2.88 million from CAD 3.05 million as cannabis revenue growth and cost savings offset reimbursement pressure.
- Quarterly free cash outflow declined to CAD 15.55 million from CAD 19.21 million, primarily reflecting working capital timing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canopy Growth Corp. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.